- Home
- AVIR vs KAZR Comparison
AVIR vs KAZR Comparison
Compare AVIR & KAZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$5.47
N/A
Current Price
$2.15
Company Overview
Basic Information| Metric | AVIR | KAZR |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.3M | 398.1M |
| IPO Year | 2020 | 2024 |
Fundamental Metrics
Financial Performance| Metric | AVIR | KAZR |
|---|---|---|
| Price | $5.47 | $2.15 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 286.5K | 133.5K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.78 | $1.60 |
| 52 Week High | $6.45 | $3.20 |
Technical Indicators
Market Signals| Indicator | AVIR | KAZR |
|---|---|---|
| Relative Strength Index (RSI) | 65.57 | 45.16 |
| Support Level | $5.13 | $1.95 |
| Resistance Level | $5.83 | $2.59 |
| Average True Range (ATR) | 0.25 | 0.17 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 92.78 | 26.03 |
Price Performance
Historical Comparison AVIR
KAZR
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.